USP18 promotes clear cell renal cell carcinoma progression by regulating the ubiquitination and stability of YBX3
, USP18 deficiency inhibits xenograft tumor growth by decreasing YBX3 expression and blocking the PI3K/AKT pathway. Our findings underscore the therapeutic potential of targeting the USP18-YBX3 axis in ccRCC treatment.
Authors
- Zhijie You
- Yihui He
- Siqi Chen
- Chen Wang
- Xin Chen (ORCID: https://orcid.org/0000-0003-3101-8580)
Institutions
- Fujian Medical University (CN)
- Fujian Provincial Hospital (CN)
Publication Details
- Journal
- iScience
- Published
- 2026-04-17
- DOI
- https://doi.org/10.1016/j.isci.2026.115808
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fujian Provincial Hospital